Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 2,167.00p on 26-02-2026 at 19:40:06
Change -47.00p -2.12%
Buy 2,168.00p
Sell 2,166.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 12,312.00 at 2,171.873p
Day's Volume: 7,370,581
Last Close: 2,167.00p
Open: 2,196.00p
ISIN: GB00BN7SWP63
Day's Range 2,154.00p - 2,211.00p
52wk Range: 1,242.50p - 2,282.00p
Market Capitalisation: £86.97b
VWAP: 2,180.96541p
Shares in Issue: 4.01b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Higher Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 12,312 2,171.873p SI Trade
Negotiated Trade
 16:47:44 - 26-Feb-26
Buy* 7,792 2,167.00p Automatic Execution
 16:39:17 - 26-Feb-26
Buy* 104 2,167.00p Automatic Execution
 16:39:17 - 26-Feb-26
Buy* 9,896 2,167.00p Automatic Execution
 16:36:30 - 26-Feb-26
Buy* 997 2,167.00p SI Trade
 16:35:21 - 26-Feb-26
Buy* 271 2,167.00p SI Trade
 16:35:21 - 26-Feb-26
Buy* 2,878 2,167.00p SI Trade
 16:35:21 - 26-Feb-26
Buy* 258 2,167.00p SI Trade
 16:35:21 - 26-Feb-26
Buy* 165 2,167.00p SI Trade
 16:35:21 - 26-Feb-26
Buy* 54 2,167.00p SI Trade
 16:35:21 - 26-Feb-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
26th Feb 2026 (Thu) 2,196.00 2,211.00 2,154.00 2,167.00 7,370,581
25th Feb 2026 (Wed) 2,182.00 2,217.00 2,176.00 2,214.00 11,628,452
24th Feb 2026 (Tue) 2,194.00 2,218.00 2,176.00 2,201.00 6,378,038
23rd Feb 2026 (Mon) 2,206.00 2,214.00 2,183.00 2,206.00 6,741,406
20th Feb 2026 (Fri) 2,237.00 2,243.00 2,200.00 2,213.00 33,732,693
19th Feb 2026 (Thu) 2,252.00 2,264.00 2,216.00 2,226.00 12,562,351
18th Feb 2026 (Wed) 2,243.00 2,282.00 2,243.00 2,268.00 13,280,520
17th Feb 2026 (Tue) 2,194.00 2,259.00 2,189.00 2,239.00 9,155,075
16th Feb 2026 (Mon) 2,172.00 2,187.00 2,153.00 2,184.00 8,105,053
13th Feb 2026 (Fri) 2,170.00 2,171.00 2,137.00 2,165.00 13,836,859
12th Feb 2026 (Thu) 2,143.00 2,149.00 2,110.00 2,141.00 4,835,448
11th Feb 2026 (Wed) 2,161.00 2,168.00 2,126.00 2,150.00 8,124,944
10th Feb 2026 (Tue) 2,163.00 2,187.00 2,132.00 2,168.00 16,786,766
9th Feb 2026 (Mon) 2,200.00 2,219.00 2,156.00 2,159.00 19,198,914
6th Feb 2026 (Fri) 2,166.00 2,198.00 2,152.00 2,198.00 8,478,262
5th Feb 2026 (Thu) 2,090.00 2,196.00 2,083.00 2,180.00 16,400,217
4th Feb 2026 (Wed) 1,935.50 2,111.00 1,920.00 2,080.00 16,788,662
3rd Feb 2026 (Tue) 1,922.50 1,945.50 1,919.00 1,945.50 6,775,935
2nd Feb 2026 (Mon) 1,882.50 1,927.50 1,875.00 1,925.00 12,846,159
30th Jan 2026 (Fri) 1,836.00 1,876.50 1,823.00 1,876.50 8,924,204
29th Jan 2026 (Thu) 1,812.00 1,859.00 1,811.00 1,852.00 9,993,355
28th Jan 2026 (Wed) 1,842.50 1,851.50 1,810.00 1,817.50 12,027,944
27th Jan 2026 (Tue) 1,834.00 1,865.50 1,832.50 1,862.50 4,702,280
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
26th Feb 2026 7:05 am RNS Linerixibat accepted for priority review in China
26th Feb 2026 7:00 am RNS Bepirovirsen accepted for Japan regulatory review
26th Feb 2026 7:00 am RNS Transaction in Own Shares
25th Feb 2026 4:54 pm RNS Director/PDMR Shareholding
25th Feb 2026 3:30 pm RNS Director/PDMR Shareholding
25th Feb 2026 7:00 am RNS GSK enters agreement to acquire 35Pharma
25th Feb 2026 7:00 am RNS Transaction in Own Shares
24th Feb 2026 3:30 pm RNS Director/PDMR Shareholding
24th Feb 2026 7:00 am RNS Transaction in Own Shares
23rd Feb 2026 7:00 am RNS Transaction in Own Shares
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

GSK moves towards clearance of two new drugs in China and Japan

26th Feb 2026 09:42

(Alliance News) - GSK PLC on Thursday reported positive regulatory momentum in Japan and China, where two of its drugs have been accepted for review. Read More

GSK buys Canadian biopharmaceutical firm 35Pharma for USD950 million

25th Feb 2026 09:30

(Alliance News) - GSK PLC on Wednesday said it has agreed to buy Canada-based clinical stage biopharmaceutical firm 35Pharma Inc for USD950 million in cash. Read More

LONDON MARKET OPEN: Stocks fall after latest tariff salvo

23rd Feb 2026 08:51

(Alliance News) - Stock prices in Europe moved lower in early dealings on Monday, with enthusiasm at the start of the week tempered by tariff uncertainty, as US President Donald Trump hit out at a Supreme Court ruling and announced new trade curbs. Read More

IN BRIEF: GSK non-executive director buys nearly GBP75,000 in shares

20th Feb 2026 15:50

GSK PLC - London-based pharmaceuticals company - Independent Non-Executive Director Wendy Becker buys 3,334 shares, at GBP22.19, worth GBP73,990, on Friday in London. Read More

LONDON BROKER RATINGS: Shore raises Sage, UBS raises St James's Place

20th Feb 2026 09:29

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,846.70
Change40.29

Login to your account

Forgot Password?

Not Registered